ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0845

Hematopoietic Specific Deficiency of Rho Kinase Attenuates Neutrophil NETosis and UVB-induced Skin Inflammation

Minghui Li1, Xing Lyu1, Yubin Li2, James Liao3, Victoria Werth4 and Ming-Lin Liu1, 1University of Pennsylvania, philadelphia, 2University of Pennsylvania and the Michael J. Crescenz VA Medical Center, Philadelphia, PA, 3University of Chicago, Chicago, 4University of Pennsylvania and Corporal Michael J. Crescenz Veterans Administration Hospital, Philadelphia

Meeting: ACR Convergence 2020

Keywords: Inflammation, lupus-like disease, neutrophils, skin

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: SLE – Animal Models Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Neutrophils are the most abundant leukocytes and the first to be recruited to the site of photodamage after ultraviolet B (UVB) exposure. We have shown that UVB induces neutrophil recruitment to the inflamed skin with NET formation and exhibition of NET-associated proinflammatory cytokines. Nuclear envelope rupture is a prerequisite for nuclear DNA release and NET formation. In our latest publication, we have identified that nuclear translocation of PKCα and its mediated lamin B phosphorylation is responsible for nuclear envelope rupture and NETosis. We have shown that application of Rho Kinase (ROCK) inhibitor HA1077 attenuates actin assembly and PKCα nuclear translocation, as well as NETosis in vitro. In our previous work, we found that intraperitoneal application of HA1077 alleviates NETosis in vivo and NET-associated proinflammatory cytokines in skin of the UVB-irradiated C57/BL6 wildtype (WT) mice.  

Methods: In the current study, to further investigate the causal role of ROCK in NET formation and UVB-induced skin inflammation, we have generated CD45.1 mice with hematopoietic specific ROCK1 deficiency by bone marrow transplantation (BMT) of hematopoietic stem cells (HSCs) from ROCK1 deficient mice, and following by UVB exposure (150 mJ/cm2, 5 consecutive days). Then we have examined IFNγ, TNFα, IL-17A expression and exhibition with NETs in skin of the UVB-irradiated skin. We also detected NET formation and cytokine release with NETs in platelet-activating factor (PAF) stimulated neutrophils from different groups of mice.

Results: In results, we found that NET formation in vitro triggered by PAF was significantly decreased in neutrophils isolated from ROCK1 deficient mice as compared to those from WT mice. Most importantly, NET formation and NET-associated IFNγ, TNFα, IL-17A were significantly attenuated in skin of UVB-irradiated CD45.1 BMT mice with ROCK1 deficiency as compared to those transplanted with HSCs from WT mice. To address what we saw in vivo, we conducted ex vivo experiment in which exhibition of neutrophil NET-associated IFNγ, TNFα, IL-17A were reduced in PAF-treated neutrophils from ROCK1 deficient mice as compared to those from WT mice.

Conclusion: In conclusion, using mice with hematopoietic specific ROCK1 deficiency, we demonstrated the role of ROCK1 in neutrophil NET formation and NET-associated proinflammatory cytokine display in UVB-induced skin inflammation. In addition, our study provide insight into a potential therapeutic strategy of targeting on ROCK as a novel potential target treatment of neutrophil NET-associated diseases and UVB-induced skin inflammation and the relevant diseases.


Disclosure: M. Li, None; X. Lyu, None; Y. Li, None; J. Liao, None; V. Werth, Corbus Pharmaceuticals, 2, Biogen, 2, 5, Resolve, 2, CSL Behring, 5, Regeneron, 5, Argenx, 5, Viela Bio, 2, 5, Principia, 5, Lilly, 5, Abbvie, 5, AstraZeneca, 2, 5, Amgen, 5, Kyowa Kirin, 5, Glaxo Smith Kline, 5, Cugene, 5, Celgene, 2, 5, Janssen, 2, 5, Pfizer, 2, 5, Gilead, 2, 5, Genentech, 2, 5, Syntimmune, 2, MedImmune, 5, Idera, 5, BMS, 5, Medscape, 5, Nektar, 5, Incyte, 5, EMD Sorona, 5, Crisalis, 5, Octapharma, 5, University of Pennsylvania, 9; M. Liu, None.

To cite this abstract in AMA style:

Li M, Lyu X, Li Y, Liao J, Werth V, Liu M. Hematopoietic Specific Deficiency of Rho Kinase Attenuates Neutrophil NETosis and UVB-induced Skin Inflammation [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/hematopoietic-specific-deficiency-of-rho-kinase-attenuates-neutrophil-netosis-and-uvb-induced-skin-inflammation/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hematopoietic-specific-deficiency-of-rho-kinase-attenuates-neutrophil-netosis-and-uvb-induced-skin-inflammation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology